← Leaderboards
Erin Allen
Magee-Women'S Res Inst And Foundation
$8,531,509
Attributed
$8,531,509
Total exposure
11
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.6M · FY2013–24$10M$7.5M$5M$2.5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,531,509 · 11
By mechanism
N01$6,382,561 · 10
N02$1,290,197 · 4
N03$858,751 · 1
Top collaborators
No co-investigators on record.
Most similar at Magee-Women'S Res Inst And Foundation
Same institution · by research overlap
- Beatrice Chen$105,730
- Mitchell Creinin$560,735
- Mitch Creinin$214,350
Others in their field
Top investigators on “National Institute Of Child Health And Human Development”
- Barbara Driver · Westat, Inc.$244,345,393
- George R Seage · Abt Associates, Inc.$190,884,554
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$169,177,396
- Abhik Das · Research Triangle Institute$165,925,750
- Daniel R Kuritzkes · Brigham And Women'S Hospital$101,405,551
Research focus
National Institute Of Child Health And Human DevelopmentWomanContraceptive AgentsSafetyContraceptive MethodsClinical TrialsMissionObesityClinical Trials NetworkUnited States Food And Drug AdministrationReproductiveProgestinsNon ObeseSiteHemorrhageContraceptive EfficacyPatternContractsProtocols DocumentationDrug KineticsDevicesPharmaceutical PreparationsInstitutesClinical Research Site
Grant awards (34)
CCTN - EVALUATION OF THE PHARMACOKINETIC PROFILE AND EFFECTS ON MECHANISMS OF CONTRACEPTION$47,060
N01 · FY2024 · HD · contact PI
CCTN - EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS$598,174
N01 · FY2023 · HD · contact PI
CCTN - EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS$384,020
N01 · FY2022 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$156,484
N01 · FY2020 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$147,391
N01 · FY2020 · HD · contact PI
CCTN - EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS$51,200
N01 · FY2020 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$216,484
N01 · FY2019 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$104,409
N01 · FY2019 · HD · contact PI
CCTN - EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS$61,638
N01 · FY2019 · HD · contact PI
CCTN - EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS$282,793
N01 · FY2018 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$156,930
N01 · FY2018 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$391,798
N01 · FY2017 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$267,496
N01 · FY2017 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$67,041
N01 · FY2017 · HD · contact PI
NEXT GENERATION STUDY, COHORT MAINTENANCE$4,546
N01 · FY2014 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$991,117
N02 · FY2013 · HD · contact PI
COLLABORATIVE PERINATAL PROJECT (CPP) MORTALITY$858,751
N03 · FY2013 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$771,914
N01 · FY2013 · HD · contact PI
CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE$707,782
N01 · FY2013 · HD · contact PI
EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS$669,827
N01 · FY2013 · HD · contact PI
Uniform Naturalistic Teenage Driving Data Set$602,577
N01 · FY2013 · HD · contact PI
STATISTICAL AND CLINICAL COORDINATING CENTER FOR CCTN (SCCC)$233,144
N01 · FY2013 · HD · contact PI
BIOMEDICAL ANALYSIS OF HUMAN BIOSPECIMENS FOR DIPHR$146,630
N02 · FY2013 · HD · contact PI
NEIGHBORHOOD CHARACTERISTICS$103,309
N01 · FY2013 · HD · contact PI
MATERNAL VITAMIN D STATUS AND MEASURES OF NEONATAL BONE MINERAL CONT$97,075
N01 · FY2013 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$58,332
N01 · FY2013 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$57,090
N02 · FY2013 · HD · contact PI
CCTN - CONTRACEPTIVE CLINIAL TRIALS NETWORK - CORE - FEMALE$51,672
N01 · FY2013 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$50,880
N01 · FY2013 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - MALE$50,140
N02 · FY2013 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$48,704
N01 · FY2013 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$45,220
N02 · FY2013 · HD · contact PI
NEXT Generation Health Study$26,437
N01 · FY2013 · HL · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$23,444
N01 · FY2013 · HD · contact PI